Azashine is used in the management of certain blood cancers and bone marrow disorders. Public sources consistently describe the following uses:

• Myelodysplastic syndrome (MDS)
• Acute myeloid leukaemia (AML) in selected patients
• Chronic myelomonocytic leukaemia (CMML) in selected patients

Azacitidine works by interfering with abnormal cell growth and affecting DNA/RNA processes in cancer cells, while helping improve the maturation and growth of healthier blood cells in the bone marrow.

Azashine is a cytotoxic anti-cancer medicine and requires careful monitoring. Safety information publicly listed for the brand includes these key points:

• Use only under specialist supervision
• Caution in kidney disease
• Caution in liver disease
• Not considered safe during breastfeeding
• Pregnancy use should be only on a doctor’s advice after risk-benefit assessment
• It may affect ability to drive in some patients due to tiredness or related side effects
• Regular blood count monitoring is important during treatment

Active Ingredient: Azacitidine